Federal Reports

For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program's drug rebate requirements, manufacturers must pay rebates to the States for the drugs. However, a prior OIG review found that States did not always invoice and collect all rebates due for drugs administered by physicians.Our objective was to determine whether New Jersey complied with Federal Medicaid requirements for invoicing manufacturers for rebates for physician-administered drugs.

Seek link below for the full report, report summary, multimedia or any agency follow-up.

This memorandum transmits the third and final report of the fiscal year 2018 financial statement audits of the Smithsonian Institution performed by the independent accounting firm of KPMG LLP.